Related Experiment Video
Updated: Jan 28, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma
Background:
The Wnt/β-catenin pathway is closely associated with osteosarcoma (OS) development and metastatic progression. We investigated the antitumor activity of Tegavivint, a novel β-catenin/transducin β-like protein 1 (TBL1) inhibitor, against OS employing in vitro, ex vivo, and in vivo cell line and patient-derived xenograft (PDX) models that recapitulate high risk disease.
Methods:
The antitumor efficacy of Tegavivint was evaluated in vitro using established OS and PDX-derived cell lines. Use of an ex vivo three-dimensional pulmonary metastasis assay assessed targeting of β-catenin activity during micro- and macrometastatic development. The in vivo activity of Tegavivint was evaluated using chemoresistant and metastatic OS PDX models. Gene and protein expression were quantified by quantitative Reverse transcription polymerase chain reaction or immunoblot analysis. Bone integrity was determined via microCT. All statistical tests were two-sided.
Results:
Tegavivint exhibited antiproliferative activity against OS cells in vitro and actively reduced micro- and macrometastatic development ex vivo. Multiple OS PDX tumors (n = 3), including paired patient primary and lung metastatic tumors with inherent chemoresistance, were suppressed by Tegavivint in vivo. We identified that metastatic lung OS cell lines (n = 2) exhibited increased stem cell signatures, including enhanced concomitant aldehyde dehydrogenase (ALDH1) and β-catenin expression and downstream activity, which were suppressed by Tegavivint (ALDH1: control group, mean relative mRNA expression = 1.00, 95% confidence interval [CI] = 0.68 to 1.22 vs Tegavivint group, mean = 0.011, 95% CI = 0.0012 to 0.056, P < .001; β-catenin: control group, mean relative mRNA expression = 1.00, 95% CI = 0.71 to 1.36 vs Tegavivint group, mean = 0.45, 95% CI = 0.36 to 0.52, P < .001). ALDH1high PDX-derived lung OS cells, which demonstrated enhanced metastatic potential compared with ALDHlow cells in vivo, were sensitive to Tegavivint. Toxicity studies revealed decreased bone density in male Tegavivint-treated mice (n = 4 mice per group).
Conclusions:
Tegavivint is a promising therapeutic agent for advanced stages of OS via its targeting of the β-catenin/ALDH1 axis.
Insights
Tegavivint effectively inhibits osteosarcoma (OS) growth and metastasis by targeting the β-catenin/ALDH1 pathway. This novel inhibitor shows promise for treating advanced OS, though bone density reduction was observed in male mice.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- The Wnt/β-catenin pathway is implicated in osteosarcoma (OS) development and metastasis.
- Targeting this pathway presents a therapeutic opportunity for OS treatment.
Purpose of the Study:
- To investigate the antitumor activity of Tegavivint, a novel β-catenin/transducin β-like protein 1 (TBL1) inhibitor, against osteosarcoma.
- To evaluate Tegavivint's efficacy in preclinical models of high-risk OS.
Main Methods:
- In vitro and ex vivo studies using OS and patient-derived xenograft (PDX) cell lines.
- In vivo evaluation in chemoresistant and metastatic OS PDX models.
- Assessment of β-catenin and aldehyde dehydrogenase 1 (ALDH1) expression and activity.
Main Results:
- Tegavivint demonstrated antiproliferative effects on OS cells and reduced pulmonary metastasis in vitro and ex vivo.
- Tegavivint suppressed tumor growth in OS PDX models, including chemoresistant and metastatic variants.
- Tegavivint decreased β-catenin and ALDH1 expression and activity in metastatic OS cells, with ALDH1high cells showing sensitivity.
Conclusions:
- Tegavivint exhibits significant antitumor activity against osteosarcoma by targeting the β-catenin/ALDH1 axis.
- Tegavivint is a potential therapeutic agent for advanced osteosarcoma.
- Further investigation into Tegavivint's toxicity, including bone density effects, is warranted.
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Hypothalamic-Pituitary Axis
Perpendicular-Axis Theorem
Consider a circular disc of mass M and radius R lying along an x-y plane. The origin lies at the center of the disc, and the z-axis is perpendicular to the disc's plane. All three axes coincide at the disc's center. The moment of inertia of this...
Parallel-axis Theorem
Load along a Single Axis
Consider a beam of length L subjected to a varying load, which is a combination of parabolic and trapezoidal load distribution along the x-axis. In this case, it is essential to determine the resultant loads, their locations, and...
Parallel-Axis Theorem for an Area
For a flywheel approximated as a solid disc, consider an infinitesimal differential element with an arbitrary distance...

